Literature DB >> 8040451

Gd-DTPA: an alternative contrast medium for CT.

A D Quinn1, N J O'Hare, F J Wallis, G F Wilson.   

Abstract

OBJECTIVE: The purpose of this study was to demonstrate that gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA) could be used as a contrast medium in CT as an alternative to iodine-based compounds.
MATERIALS AND METHODS: Solutions of different concentrations of Gd-DTPA and iopromide were scanned in a tissue equivalent phantom and it was shown that Gd-DTPA caused 2.5 times the attenuation of an equimolar solution of iopromide. From these in vitro studies an in vivo dose of 0.5 mmol/kg Gd-DTPA was calculated to be equivalent to 50 ml iopromide 300.
RESULTS: Pre- and postenhancement CT was performed in a volunteer using Gd-DTPA intravenously, and adequate enhancement occurred in intracranial vessels.
CONCLUSION: Gd-DTPA can be used to provide enhancement during CT and might be of value in iodine-sensitive patients.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8040451

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  8 in total

Review 1.  Updated guidelines for intravenous contrast use for CT and MRI.

Authors:  Kevin Huynh; Arthur H Baghdanian; Armonde A Baghdanian; Derek S Sun; K Pallav Kolli; Ronald J Zagoria
Journal:  Emerg Radiol       Date:  2020-01-10

2.  Gadopentetate dimeglumine as a contrast agent in common carotid arteriography.

Authors:  W K Erly; J Zaetta; G T Borders; H Ozgur; D R Gabaeff; R F Carmody; J Seeger
Journal:  AJNR Am J Neuroradiol       Date:  2000-05       Impact factor: 3.825

3.  Iodine contrast iso-attenuating with diagnostic gadolinium doses in CTA and angiography results in ultra-low iodine doses. A way to avoid both CIN and NSF in azotemic patients?

Authors:  Ulf Nyman; Barbara Elmståhl; Håkan Geijer; Peter Leander; Torsten Almén; Mats Nilsson
Journal:  Eur Radiol       Date:  2010-08-29       Impact factor: 5.315

4.  Gadolinium-enhanced CT angiography of the circle of Willis and neck.

Authors:  John W Henson; Raul G Nogueira; Diego J Covarrubias; R Gilberto Gonzalez; Michael H Lev
Journal:  AJNR Am J Neuroradiol       Date:  2004 Jun-Jul       Impact factor: 3.825

Review 5.  Actual clinical use of gadolinium-chelates for non-MRI applications.

Authors:  Holger M Strunk; H Schild
Journal:  Eur Radiol       Date:  2004-02-10       Impact factor: 5.315

6.  Arterial angiography in high-kilovoltage technique with gadolinium as the contrast agent: first clinical experience.

Authors:  F Fobbe; F Wacker; S Wagner
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

Review 7.  Multimodal MRI contrast agents.

Authors:  Luca Frullano; Thomas J Meade
Journal:  J Biol Inorg Chem       Date:  2007-07-21       Impact factor: 3.862

8.  Potential dual imaging nanoparticle: Gd2O3 nanoparticle.

Authors:  Md Wasi Ahmad; Wenlong Xu; Sung June Kim; Jong Su Baeck; Yongmin Chang; Ji Eun Bae; Kwon Seok Chae; Ji Ae Park; Tae Jeong Kim; Gang Ho Lee
Journal:  Sci Rep       Date:  2015-02-24       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.